285 related articles for article (PubMed ID: 27167000)
21. Meloxicam combined with sorafenib synergistically inhibits tumor growth of human hepatocellular carcinoma cells via ER stress-related apoptosis.
Zhong J; Xiu P; Dong X; Wang F; Wei H; Wang X; Xu Z; Liu F; Li T; Wang Y; Li J
Oncol Rep; 2015 Oct; 34(4):2142-50. PubMed ID: 26252057
[TBL] [Abstract][Full Text] [Related]
22. RACK1 modulates apoptosis induced by sorafenib in HCC cells by interfering with the IRE1/XBP1 axis.
Zhou T; Lv X; Guo X; Ruan B; Liu D; Ding R; Gao Y; Ding J; Dou K; Chen Y
Oncol Rep; 2015 Jun; 33(6):3006-14. PubMed ID: 25901709
[TBL] [Abstract][Full Text] [Related]
23. Unfolded protein response activation contributes to chemoresistance in hepatocellular carcinoma.
Al-Rawashdeh FY; Scriven P; Cameron IC; Vergani PV; Wyld L
Eur J Gastroenterol Hepatol; 2010 Sep; 22(9):1099-105. PubMed ID: 20177386
[TBL] [Abstract][Full Text] [Related]
24. Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells.
Rodvold JJ; Chiu KT; Hiramatsu N; Nussbacher JK; Galimberti V; Mahadevan NR; Willert K; Lin JH; Zanetti M
Sci Signal; 2017 Jun; 10(482):. PubMed ID: 28588081
[TBL] [Abstract][Full Text] [Related]
25. Arsenic trioxide induces unfolded protein response in vascular endothelial cells.
Weng CY; Chiou SY; Wang L; Kou MC; Wang YJ; Wu MJ
Arch Toxicol; 2014 Feb; 88(2):213-26. PubMed ID: 23892647
[TBL] [Abstract][Full Text] [Related]
26. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
27. Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress.
Wallington-Beddoe CT; Bennett MK; Vandyke K; Davies L; Zebol JR; Moretti PAB; Pitman MR; Hewett DR; Zannettino ACW; Pitson SM
Oncotarget; 2017 Jul; 8(27):43602-43616. PubMed ID: 28467788
[TBL] [Abstract][Full Text] [Related]
28. Xanthatin induces apoptosis by activating endoplasmic reticulum stress in hepatoma cells.
Shi TL; Zhang L; Cheng QY; Yu JS; Liu J; Shen YJ; Feng XJ; Shen YX
Eur J Pharmacol; 2019 Jan; 843():1-11. PubMed ID: 30389633
[TBL] [Abstract][Full Text] [Related]
29. Carfilzomib and oprozomib synergize with histone deacetylase inhibitors in head and neck squamous cell carcinoma models of acquired resistance to proteasome inhibitors.
Zang Y; Kirk CJ; Johnson DE
Cancer Biol Ther; 2014 Sep; 15(9):1142-52. PubMed ID: 24915039
[TBL] [Abstract][Full Text] [Related]
30. Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir-bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death.
Johnson CE; Dunlop EA; Seifan S; McCann HD; Hay T; Parfitt GJ; Jones AT; Giles PJ; Shen MH; Sampson JR; Errington RJ; Davies DM; Tee AR
Oncogene; 2018 Nov; 37(45):5913-5925. PubMed ID: 29980790
[TBL] [Abstract][Full Text] [Related]
31. Differential sensitivity of hepatocellular carcinoma cells to suppression of hepatocystin transcription under hypoxic conditions.
Yoo JJ; Lee DH; Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
J Bioenerg Biomembr; 2016 Dec; 48(6):581-590. PubMed ID: 27640193
[TBL] [Abstract][Full Text] [Related]
32. Sorafenib and Carfilzomib Synergistically Inhibit the Proliferation, Survival, and Metastasis of Hepatocellular Carcinoma.
Jiang C; Xu R; Li XX; Zhou YF; Xu XY; Yang Y; Wang HY; Zheng XFS
Mol Cancer Ther; 2018 Dec; 17(12):2610-2621. PubMed ID: 30224431
[TBL] [Abstract][Full Text] [Related]
33. Molecular Insight Into the IRE1α-Mediated Type I Interferon Response Induced by Proteasome Impairment in Myeloid Cells of the Brain.
Studencka-Turski M; Çetin G; Junker H; Ebstein F; Krüger E
Front Immunol; 2019; 10():2900. PubMed ID: 31921161
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors.
Prelowska MK; Mehlich D; Ugurlu MT; Kedzierska H; Cwiek A; Kosnik A; Kaminska K; Marusiak AA; Nowis D
Cancer Lett; 2021 Jun; 507():13-25. PubMed ID: 33713737
[TBL] [Abstract][Full Text] [Related]
35. Modulation of the unfolded protein response is the core of microRNA-122-involved sensitivity to chemotherapy in hepatocellular carcinoma.
Yang F; Zhang L; Wang F; Wang Y; Huo XS; Yin YX; Wang YQ; Zhang L; Sun SH
Neoplasia; 2011 Jul; 13(7):590-600. PubMed ID: 21750653
[TBL] [Abstract][Full Text] [Related]
36. Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma.
Hui B; Shi YH; Ding ZB; Zhou J; Gu CY; Peng YF; Yang H; Liu WR; Shi GM; Fan J
Cancer; 2012 Nov; 118(22):5560-71. PubMed ID: 22517429
[TBL] [Abstract][Full Text] [Related]
37. The PERK-eIF2α signaling pathway is involved in TCDD-induced ER stress in PC12 cells.
Duan Z; Zhao J; Fan X; Tang C; Liang L; Nie X; Liu J; Wu Q; Xu G
Neurotoxicology; 2014 Sep; 44():149-59. PubMed ID: 24932542
[TBL] [Abstract][Full Text] [Related]
38. Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma.
Bagi CM; Gebhard DF; Andresen CJ
Eur J Gastroenterol Hepatol; 2012 May; 24(5):563-74. PubMed ID: 22314934
[TBL] [Abstract][Full Text] [Related]
39. Combined inhibition of Hsp90 and the proteasome affects NSCLC proteostasis and attenuates cell migration.
Zismanov V; Drucker L; Gottfried M
Anticancer Drugs; 2014 Oct; 25(9):998-1006. PubMed ID: 25153785
[TBL] [Abstract][Full Text] [Related]
40. Calcium channel blocker verapamil enhances endoplasmic reticulum stress and cell death induced by proteasome inhibition in myeloma cells.
Meister S; Frey B; Lang VR; Gaipl US; Schett G; Schlötzer-Schrehardt U; Voll RE
Neoplasia; 2010 Jul; 12(7):550-61. PubMed ID: 20651984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
